{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,29]],"date-time":"2026-10-29T02:08:51Z","timestamp":1793239731845,"version":"4.5.0"},"reference-count":36,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"5","license":[{"start":{"date-parts":[[2024,6,10]],"date-time":"2024-06-10T00:00:00Z","timestamp":1717977600000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/ http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2024,7]]},"abstract":"<jats:sec>\n            <jats:title>Objective:<\/jats:title>\n            <jats:p>Sickle cell disease (SCD) is a common hereditary hemoglobin disorder worldwide. One of the main treatments for patients with SCD is the requirement for blood transfusions. Posttransfusion alloimmunization with red blood cell (RBC) antigens continues to be a major risk factor for SCD. The objective of this study was to determine the rate, nature, and risk factors of red cell alloimmunization among pediatric patients with SCD in our center and compare our results with published reports from Saudia Arabia SA, regional countries, and some international countries.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Materials and Methods:<\/jats:title>\n            <jats:p>A retrospective chart review of patients with SCD at King Abdulaziz Medical City\u2013Jeddah, between 2008 and 2019 was performed. Demographic characteristics and transfusion histories were recorded. Blood samples were analyzed for alloimmunization using immunohematologic techniques.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Results:<\/jats:title>\n            <jats:p>In total, 121 patients were analyzed. Alloantibodies were detected in 21 patients (17.4%) and were mostly single in 15 patients (71.4%), anti-K (23.7%), anti-E (19.0%), and anti-S (9.5%). The other 6 patients (28.6%) had multiple alloantibodies, especially the combination of anti-C and anti-K (9.5%) and the combination of anti-C and anti-E (9.5%). Alloantibody levels were significantly higher in patients with frequent hospital admissions (&gt;5 times annually), those who had an exchange blood transfusion, those younger than 3 years old, and those who received a larger number of blood units (<jats:italic toggle=\"yes\">P<\/jats:italic> \u22640.05).<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Conclusion:<\/jats:title>\n            <jats:p>The rate of RBC alloimmunization is determined and considered relatively low compared with that in other nations. Matching for extended RBC antigens to include ABO, RH (D, C, c, E, e), K, Fy<jats:sup>a<\/jats:sup>, Fy<jats:sup>b<\/jats:sup>, Jk<jats:sup>a<\/jats:sup>, and Jk<jats:sup>b<\/jats:sup> antigens in the screening panel for donors and recipients is highly recommended to ensure better transfusion practices and avoid transfusion-related complications.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1097\/mph.0000000000002889","type":"journal-article","created":{"date-parts":[[2024,6,10]],"date-time":"2024-06-10T14:00:09Z","timestamp":1718028009000},"page":"e284-e289","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":5,"title":["Prevalence of Red Blood Cell Alloimmunization Among Pediatric Patients With Sickle Cell Disease in Saudi Arabia"],"prefix":"10.1097","volume":"46","author":[{"given":"Badriah","family":"Al-Asmari","sequence":"first","affiliation":[{"name":"Department of Pediatric Hematology and Oncology, Princess Norah Oncology Center, King Abdul Aziz Medical City-Jeddah (KAMC-J)"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abdullah","family":"Baothman","sequence":"additional","affiliation":[{"name":"Department of Pediatric Hematology and Oncology, Princess Norah Oncology Center, King Abdul Aziz Medical City-Jeddah (KAMC-J)"},{"name":"Department of pediatric, College of Medicine, King Saud Bin Abdul Aziz University for Health Science"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohammed","family":"Almohammadi","sequence":"additional","affiliation":[{"name":"Department of Pathology and Laboratory Medicine, KAMC-J, Saudi Arabia. College of Medicine, KSAU-HS"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohammed","family":"Aljuaid","sequence":"additional","affiliation":[{"name":"Department of Pediatrics\u2014Royal commission hospital, Yanbu, Saudi Arabia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wasil","family":"Jastaniah","sequence":"additional","affiliation":[{"name":"Department of Oncology Center, King Faisal Specialist Hospital and Research Center (Gen.Org.), Jeddah"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2024,6,10]]},"reference":[{"key":"R1-20250804","first-page":"1480","article-title":"The prevalence of sickle cell disease in Saudi children and adolescents. A community-based survey","volume":"29","author":"Al-Qurashi","year":"2008","journal-title":"Saudi Med J"},{"key":"R2-20250804","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1038\/198492b0","article-title":"Distribution of sickle-cell hemoglobin in Saudi Arabia","volume":"198","author":"Lehmann","year":"1963","journal-title":"Nature"},{"key":"R3-20250804","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1097\/GIM.0b013e318065a9e8","article-title":"Premarital screening for thalassemia and sickle cell disease in Saudi Arabia","volume":"9","author":"AlHamdan","year":"2007","journal-title":"Genet Med"},{"key":"R4-20250804","first-page":"895","article-title":"Sickle cell disease in children","volume":"72","author":"Meier","year":"2012","journal-title":"Drugs"},{"key":"R5-20250804","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1016\/j.hoc.2005.07.002","article-title":"Transfusion management in sickle cell disease","volume":"19","author":"Wanko","year":"2005","journal-title":"Hematol Oncol Clin North Am"},{"key":"R6-20250804","doi-asserted-by":"crossref","first-page":"e2017013","DOI":"10.4084\/mjhid.2017.013","article-title":"Alloimmunization in patients with sickle cell disease and thalassemia: experience of a single centre in Oman","volume":"9","author":"Alkindi","year":"2017","journal-title":"Mediterr J Hematol Infect Dis"},{"key":"R7-20250804","doi-asserted-by":"crossref","first-page":"1649","DOI":"10.1111\/j.1537-2995.2009.02185.x","article-title":"Red blood cell alloimmunization among sickle cell Kuwaiti Arab patients who received red blood cell transfusion","volume":"49","author":"Ameen","year":"2009","journal-title":"Transfusion"},{"key":"R8-20250804","doi-asserted-by":"crossref","first-page":"1181","DOI":"10.26719\/2007.13.5.1181","article-title":"Red cell alloimmunization in sickle-cell anaemia patients","volume":"13","author":"Bashawri","year":"2007","journal-title":"East Mediterr Health J"},{"key":"R9-20250804","doi-asserted-by":"crossref","first-page":"17","DOI":"10.4197\/Med.22-3.5","article-title":"Red blood cell alloimmunization in sickle cell disease patients in Jeddah, Saudi Arabia: a pilot study","volume":"22","author":"Alboog","year":"2015","journal-title":"JKAU Med Sci"},{"key":"R10-20250804","doi-asserted-by":"crossref","first-page":"1431","DOI":"10.1182\/blood.V76.7.1431.1431","article-title":"Transfusion and alloimmunization in sickle cell disease. The cooperative study of sickle cell disease","volume":"76","author":"Rosse","year":"1990","journal-title":"Blood"},{"key":"R11-20250804","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1002\/ajh.2830050204","article-title":"Post-transfusion alloimmunization in patients with sickle cell disease","volume":"5","author":"Orlina","year":"1978","journal-title":"Am J Hematol"},{"key":"R12-20250804","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1111\/j.1399-0039.1987.tb01615.x","article-title":"Alloantibody responses in multiply transfused sickle cell patients","volume":"30","author":"Reisner","year":"1987","journal-title":"Tissue Antigens"},{"key":"R13-20250804","doi-asserted-by":"crossref","first-page":"35","DOI":"10.4103\/joah.joah_122_21","article-title":"The prevalence of cumulative alloimmunization in patients with sickle cell disease at King Fahad University Hospital","volume":"13","author":"AlDawood","year":"2022","journal-title":"J Appl Hematol"},{"key":"R14-20250804","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1111\/voxs.12362","article-title":"Alloimmunisation and nephropathy in sickle cell disease patients in Jeddah, Saudi Arabia","volume":"12","author":"Adam","year":"2017","journal-title":"ISBT Scie Series"},{"key":"R15-20250804","doi-asserted-by":"crossref","first-page":"5356245","DOI":"10.1155\/2018\/5356245","article-title":"Frequency of red blood cell alloimmunization in patients with sickle cell disease in Palestine","volume":"2018","author":"Samarah","year":"2018","journal-title":"Adv Hematol"},{"issue":"suppl 1","key":"R16-20250804","first-page":"S15","article-title":"The value of transfusion of phenotyped blood units for thalassemia and sickle cell anemia patients at an academic center","volume":"60","author":"Hindawi","year":"2020","journal-title":"Transfusion"},{"key":"R17-20250804","doi-asserted-by":"crossref","first-page":"4093","DOI":"10.2147\/IJGM.S360320","article-title":"Red cell alloimmunization and autoimmunization among sickle cell disease and thalassemia patients in Jazan Province, Saudi Arabia","volume":"15","author":"Halawani","year":"2022","journal-title":"Int J Gen Med"},{"key":"R18-20250804","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1016\/j.transci.2008.09.013","article-title":"Transfusion medicine in a developing country - alloantibodies to red blood cells in multi-transfused patients in Saudi Arabia","volume":"39","author":"Gader","year":"2008","journal-title":"Transfus Apher Sci"},{"key":"R19-20250804","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1046\/j.1365-2141.2001.02819.x","article-title":"Red cell antibodies in patients with homozygous sickle cell disease: a comparison of patients in Jamaica and the United Kingdom","volume":"113","author":"Olujohungbe","year":"2001","journal-title":"Br J Haematol"},{"key":"R20-20250804","first-page":"136","article-title":"Alloimmunization and clinical profile of sickle cell disease patients from Salvador-Brazil","volume":"20","author":"Dias Zanette","year":"2010","journal-title":"Ethn Dis"},{"key":"R21-20250804","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1016\/j.htct.2021.03.003","article-title":"Frequency of Rh and K antigens in blood donors in Riyadh","volume":"44","author":"Alalshaikh","year":"2022","journal-title":"Hematol Transfus Cell Ther"},{"key":"R22-20250804","doi-asserted-by":"crossref","first-page":"2773","DOI":"10.1182\/blood-2018-02-785964","article-title":"How I safely transfuse patients with sickle-cell disease and manage delayed hemolytic transfusion reactions","volume":"131","author":"Pirenne","year":"2018","journal-title":"Blood"},{"key":"R23-20250804","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1016\/j.crvi.2012.09.011","article-title":"Relevance of blood groups in transfusion of sickle cell disease patients","volume":"336","author":"Noizat-Pirenne","year":"2013","journal-title":"C R Biol"},{"key":"R24-20250804","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1002\/ajh.24397","article-title":"Early occurrence of red blood cell alloimmunization in patients with sickle cell disease","volume":"91","author":"Sins","year":"2016","journal-title":"Am J Hematol"},{"key":"R25-20250804","first-page":"95","article-title":"Alloimmunization to red cell antigens in thalassemia: comparative study of usual versus better-match transfusion programmes","volume":"52","author":"Michail-Merianou","year":"1987","journal-title":"Vox Sang"},{"key":"R26-20250804","doi-asserted-by":"crossref","first-page":"528","DOI":"10.1182\/blood-2011-11-327361","article-title":"Red blood cell alloimmunization in sickle cell disease: pathophysiology, risk factors, and transfusion management","volume":"120","author":"Yazdanbakhsh","year":"2012","journal-title":"Blood"},{"key":"R27-20250804","doi-asserted-by":"crossref","first-page":"1086","DOI":"10.1046\/j.1537-2995.2001.41091086.x","article-title":"Prospective RBC phenotype matching in a stroke-prevention trial in sickle cell anemia: a multicenter transfusion trial","volume":"41","author":"Vichinsky","year":"2001","journal-title":"Transfusion"},{"key":"R28-20250804","doi-asserted-by":"crossref","first-page":"1732","DOI":"10.1111\/j.1537-2995.2010.03045.x","article-title":"Extended red blood cell antigen matching for transfusions in sickle cell disease: a review of a 14-year experience from a single center (CME)","volume":"51","author":"Lasalle-Williams","year":"2011","journal-title":"Transfusion"},{"key":"R29-20250804","first-page":"50","article-title":"Red cell alloantibodies in patients with thalassemia","volume":"58","author":"Spanos","year":"1990","journal-title":"Vox Sang"},{"key":"R30-20250804","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1002\/pbc.22985","article-title":"Red cell exchange does not appear to increase the rate of allo- and auto-immunization in chronically transfused children with sickle cell disease","volume":"57","author":"Venkateswaran","year":"2011","journal-title":"Pediatr Blood Cancer"},{"key":"R31-20250804","doi-asserted-by":"crossref","first-page":"2485","DOI":"10.1001\/archinte.1988.00380110115024","article-title":"Risk of alloimmunization and delayed hemolytic transfusion reactions in patients with sickle cell disease","volume":"148","author":"Cox","year":"1988","journal-title":"Arch Intern Med"},{"key":"R32-20250804","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1046\/j.1537-2995.1986.26386209381.x","article-title":"The incidence of development of irregular red cell antibodies in patients with sickle cell anemia","volume":"26","author":"Sarnaik","year":"1986","journal-title":"Transfusion"},{"issue":"suppl 1","key":"R33-20250804","doi-asserted-by":"crossref","first-page":"5078","DOI":"10.1182\/blood-2018-99-119837","article-title":"Minimising transfusion therapy and alloimmunisation in patients with sickle cell disorder in the era of hydroxyurea","volume":"132","author":"Smith","year":"2018","journal-title":"Blood"},{"key":"R34-20250804","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1111\/bjh.13123","article-title":"Red blood cell alloimmunization is influenced by recipient inflammatory state at time of transfusion in patients with sickle cell disease","volume":"168","author":"Fasano","year":"2015","journal-title":"Br J Haematol"},{"key":"R35-20250804","doi-asserted-by":"crossref","first-page":"3369","DOI":"10.1182\/blood.V96.10.3369","article-title":"Alloimmunization and erythrocyte autoimmunization in transfusion-dependent thalassemia patients of predominantly Asian descent","volume":"96","author":"Singer","year":"2000","journal-title":"Blood"},{"key":"R36-20250804","doi-asserted-by":"crossref","first-page":"1135","DOI":"10.1002\/ajh.24188","article-title":"Immunophenotypic parameters and RBC alloimmunization in children with sickle cell disease on chronic transfusion","volume":"90","author":"Nickel","year":"2015","journal-title":"Am J Hematol"}],"container-title":["Journal of Pediatric Hematology\/Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/MPH.0000000000002889","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,8,4]],"date-time":"2025-08-04T20:06:54Z","timestamp":1754338014000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/MPH.0000000000002889"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,6,10]]},"references-count":36,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2024]]}},"URL":"https:\/\/doi.org\/10.1097\/mph.0000000000002889","relation":{},"ISSN":["1077-4114"],"issn-type":[{"value":"1077-4114","type":"print"}],"subject":[],"published":{"date-parts":[[2024,6,10]]},"assertion":[{"value":"2023-10-30","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2024-03-13","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}